The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Prostaglandin E2 Increases Growth and Motility of Colorectal Carcinoma Cells
Open accessAbstract
Chronic use of nonsteroidal anti-inflammatory drugs results in a significant reduction of risk and mortality from colorectal cancer in humans. All of the mechanism(s) by which nonsteroidal anti-inflammatory drugs exert their protective effects are not completely understood, but they are known to inhibit cyclooxygenase activity. The cyclooxygenase enzymes catalyze a key reaction in the conversion of arachidonic acid to prostaglandins, such as prostaglandin E(2) (PGE(2)). Here we demonstrate that PGE(2) treatment of LS-174 human colorectal carcinoma cells leads to increased motility and changes in cell shape. The prostaglandin EP(4) receptor signaling pathway appears to play a role in transducing signals which regulate these effects. PGE(2) treatment results in an activation of phosphatidylinositol 3-kinase/protein kinase B pathway that is required for the PGE(2)-induced changes in carcinoma cell motility and colony morphology. Our results suggest that PGE(2) might enhance the invasive potential of colorectal carcinoma cells via activation of major intracellular signal transduction pathways not previously reported to be regulated by prostaglandins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vlahos, C. J., Matter, W. F., Hui, K. Y., & Brown, R. F. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37680-9 · Cited by 3,240
The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous Polyposis
Steinbach, G., Lynch, P. M., Phillips, R. K. S., Wallace, M. H., Hawk, E., Gordon, G. B., Wakabayashi, N., Saunders, B., Shen, Y., Fujimura, T., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006293422603 · Cited by 2,526
Self-citationUp-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas
Eberhart, C. E., Coffey, R. J., Radhika, A., Giardiello, F. M., Ferrenbach, S., & Dubois, R. N. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90246-1 · Cited by 2,514
Self-citationCyclooxygenase in biology and disease
DuBois, R. N., Abramson, S. B., Crofford, L., Gupta, R. A., Simon, L. S., van de Putte, L. B. A., & Lipsky, P. E. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.12.1063 · Cited by 2,506
Self-citationOshima, M., Dinchuk, J. E., Kargman, S. L., Oshima, H., Hancock, B., Kwong, E., Trzaskos, J. M., Evans, J. F., & Taketo, M. M. (1996) · Cell · doi:10.1016/s0092-8674(00)81988-1 · Cited by 2,366
Tsujii, M., & DuBois, R. N. (1995) · Cell · doi:10.1016/0092-8674(95)90127-2 · Cited by 2,267
Self-citationGlycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization
Diehl, J. A., Cheng, M., Roussel, M. F., & Sherr, C. J. (1998) · Genes & Development · doi:10.1101/gad.12.22.3499 · Cited by 2,130
Franke, T. F., Yang, S.-I., Chan, T. O., Datta, K., Kazlauskas, A., Morrison, D. K., Kaplan, D. R., & Tsichlis, P. N. (1995) · Cell · doi:10.1016/0092-8674(95)90534-0 · Cited by 2,006
AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1
Medema, R. H., Kops, G. J. P. L., Bos, J. L., & Burgering, B. M. T. (2000) · Nature · doi:10.1038/35008115 · Cited by 1,438
The role of cyclooxygenases in inflammation, cancer, and development
Williams, C. S., Mann, M., & DuBois, R. N. (1999) · Oncogene · doi:10.1038/sj.onc.1203286 · Cited by 1,417
Self-citationCyclooxygenase-2 expression in human colon cancer cells increases metastatic potential
Tsujii, M., Kawano, S., & DuBois, R. N. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3336 · Cited by 1,398
Self-citationRequirement for Phosphatidylinositol-3 Kinase in the Prevention of Apoptosis by Nerve Growth Factor
Yao, R., & Cooper, G. M. (1995) · Science · doi:10.1126/science.7701324 · Cited by 1,391
Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells.
Sheng, H., Shao, J., Morrow, J. D., Beauchamp, R. D., & Dubois, R. N. (1998) · PubMed · Cited by 1,114
Self-citationAspirin and the Risk of Colorectal Cancer in Women
Giovannucci, E., Egan, K. M., Hunter, D. J., Stampfer, M. J., Colditz, G. A., Willett, W. C., & Speizer, F. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509073331001 · Cited by 1,090
Rodriguez-Viciana, P., Warne, P. H., Khwaja, A., Marte, B. M., Pappin, D., Das, P., Waterfield, M. D., Ridley, A., & Downward, J. (1997) · Cell · doi:10.1016/s0092-8674(00)80226-3 · Cited by 1,061
Aspirin use and risk of fatal cancer.
Thun, M. J., Namboodiri, M. M., Calle, E. E., Flanders, W. D., & Heath, C. W. (1993) · PubMed · Cited by 870
Signaling by Distinct Classes of Phosphoinositide 3-Kinases
Vanhaesebroeck, B., & Waterfield, M. D. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4701 · Cited by 853
Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer.
Kargman, S., O’Neill, G. P., Vickers, P. J., Evans, J. F., Mancini, J. A., & Jothy, S. (1995) · PubMed · Cited by 824
Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.
Sheng, H., Shao, J., Kirkland, S. C., Isakson, P., Coffey, R. J., Morrow, J., Beauchamp, R. D., & DuBois, R. N. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119400 · Cited by 712
Self-citationExpression of mRNA for cyclooxygenase‐1 and cyclooxygenase‐2 in human tissues
O'Neill, G. P., & Ford-Hutchinson, A. W. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80263-t · Cited by 707
Chemotaxis in Eukaryotic Cells: A Focus on Leukocytes and Dictyostelium
Devreotes, P. N., & Zigmond, S. H. (1988) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.04.110188.003245 · Cited by 629
The Gβγ Sensitivity of a PI3K Is Dependent upon a Tightly Associated Adaptor, p101
Stephens, L. R., Eguinoa, A., Erdjument-Bromage, H., Lui, M., Cooke, F., Coadwell, J., Smrcka, A. S., Thelen, M., Cadwallader, K., Tempst, P., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80187-7 · Cited by 557
Muise-Helmericks, R. C., Grimes, H. L., Bellacosa, A., Malstrom, S. E., Tsichlis, P. N., & Rosen, N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.45.29864 · Cited by 511
Kiriyama, M., Ushikubi, F., Kobayashi, T., Hirata, M., Sugimoto, Y., & Narumiya, S. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701367 · Cited by 510
Reddy, B. S., Hirose, Y., Lubet, R. A., Steele, V. E., Kelloff, G. J., Paulson, S. K., Seibert, K., & Rao, C. V. (2000) · PubMed · Cited by 457
Regulation of chemotaxis by the platelet-derived growth factor receptor-β
Kundra, V., Escobedo, J. A., Kazlauskas, A., Kim, H. K., Rhee, S. G., Williams, L. T., & Zetter, B. R. (1994) · Nature · doi:10.1038/367474a0 · Cited by 439
Multiple Ras Effector Pathways Contribute to G1Cell Cycle Progression
Gille, H., & Downward, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.31.22033 · Cited by 409
Role of the prostaglandin E receptor subtype EP1 in colon carcinogenesis.
Watanabe, K., Kawamori, T., Nakatsugi, S., Ohta, T., Ohuchida, S., Yamamoto, H., Maruyama, T., Kondo, K., Ushikubi, F., Narumiya, S., et al. (1999) · PubMed · Cited by 351
Activation of Akt/Protein Kinase B by G Protein-coupled Receptors
Murga, C., Laguinge, L., Wetzker, R., Cuadrado, A., & Gutkind, J. S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.30.19080 · Cited by 331
Chen, P., Xie, H., Sekar, M. C., Gupta, K., & Wells, A. (1994) · The Journal of cell biology · doi:10.1083/jcb.127.3.847 · Cited by 325
Molecular cloning and characterization of the four rat prostaglandin E2 prostanoid receptor subtypes
Boie, Y., Stocco, R., Sawyer, N., Slipetz, D. M., Ungrin, M. D., Neuschäfer-Rube, F., Püschel, G. P., Metters, K. M., & Abramovitz, M. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01383-6 · Cited by 296
Microfilament Structure and Function in the Cortical Cytoskeleton
Bretscher, A. (1991) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.07.110191.002005 · Cited by 274
Mechanism of Protein Kinase B Activation by Cyclic AMP-Dependent Protein Kinase
Filippa, N., Sable, C. L., Filloux, C., Hemmings, B., & Van Obberghen, E. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.7.4989 · Cited by 258
Regulation of Constitutive Cyclooxygenase-2 Expression in Colon Carcinoma Cells
Shao, J., Sheng, H., Inoue, H., Morrow, J. D., & DuBois, R. N. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002324200 · Cited by 257
Self-citationJiang, K., Coppola, D., Crespo, N. C., Nicosia, S. V., Hamilton, A. D., Sebti, S. M., & Cheng, J. Q. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.1.139-148.2000 · Cited by 240
Localization of Cyclooxygenase-2 in Human Sporadic Colorectal Adenomas
Chapple, K. S., Cartwright, E. J., Hawcroft, G., Tisbury, A., Bonifer, C., Scott, N., Windsor, A. C. J., Guillou, P. J., Markham, A. F., Coletta, P. L., et al. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64759-1 · Cited by 218
Aspirin and Nonsteroidal Anti-inflammatory Drug Use and the Risk of Subsequent Colorectal Cancer
Peleg, I. I. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.154.4.394 · Cited by 213
Murga, C., Fukuhara, S., & Gutkind, J. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.16.12069 · Cited by 197
PI 3-kinase: a pivotal pathway in T-cell activation?
Ward, S. G., June, C. H., & Olive, D. (1996) · Immunology Today · doi:10.1016/0167-5699(96)80618-9 · Cited by 178
cAMP stimulates protein kinase B in a Wortmannin‐insensitive manner
Sable, C. L., Filippa, N., Hemmings, B., & Van Obberghen, E. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00518-8 · Cited by 166
Smith, C. J., Morrow, J. D., Roberts, L. J., & Marnett, L. J. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1483 · Cited by 124
Stimulation of matrix metalloproteinase‐dependent migration of T cells by eicosanoids
Leppert, D., Hauser, S. L., Kishiyama, J. L., An, S. M., Zeng, L., & Goetzl, E. J. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.14.7589989 · Cited by 117
Prostaglandin receptors: their role in regulating renal function
Breyer, M. D., & BREYER, R. M. (2000) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200001000-00005 · Cited by 101
Osada, M., Tolkacheva, T., Li, W., Chan, T. O., Tsichlis, P. N., Sáez, R., Kimmelman, A. C., & Chan, A. M.-L. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.9.6333 · Cited by 95
Salmon, E. D. (1989) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(89)90018-5 · Cited by 69
1 Role of phosphoinositide-3-OH kinase in ras signaling
Downward, J. (1997) · Advances in second messenger and phosphoprotein research · doi:10.1016/s1040-7952(97)80004-3 · Cited by 55
An EP receptor with a novel pharmacological profile in the T‐cell line Jurkat
Vries, G. W. D., Guarino, P., McLaughlin, A. P., Chen, J., Andrews, S. W., & Woodward, D. F. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb15030.x · Cited by 23
Cited by
Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition
Simmons, D. L., Botting, R. M., & Hla, T. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.3.3 · Cited by 1,693
Greenhough, A., Smartt, H. J. M., Moore, A. E., Roberts, H. R., Williams, A. C., Paraskeva, C., & Kaidi, A. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp014 · Cited by 1,220
Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2
Gupta, R. A., & DuBois, R. N. (2001) · Nature Reviews Cancer · doi:10.1038/35094017 · Cited by 1,066
Self-citationWang, D. (2006) · Gut · doi:10.1136/gut.2004.047100 · Cited by 899
Pai, R., Soreghan, B., Szabo, I. L., Pavelka, M., Baatar, D., & Tarnawski, A. S. (2002) · Nature Medicine · doi:10.1038/nm0302-289 · Cited by 836
Metadata
- Authors
- Sheng, H., Shao, J., Washington, M. K., & DuBois, R. N.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2001-05
- Volume
- 276
- Issue
- 21
- Pages
- 18075-18081
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2087744847
- Cited by
- 653
- References
- 47
- FWCI
- 30.35
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.